XML 38 R29.htm IDEA: XBRL DOCUMENT v3.23.1
Share-Based Compensation and Capital Stock (Tables)
3 Months Ended
Mar. 31, 2023
Share-Based Payment Arrangement [Abstract]  
Schedule of Pre-Tax Stock-Based Compensation Expenses The components of the Company’s pretax share-based compensation activity are as follows for the three months ended March 31, 2023 and 2022:
Three Months Ended March 31,
(in thousands)20232022
Stock options$1,388 $1,052 
Restricted stock awards3,699 3,043 
Performance vested restricted stock units4,684 3,354 
Total share-based compensation expense$9,771 $7,449 
Schedule of Change In Stock-Based Award Activity
A summary of share-based award activity as of and changes during the three months ended March 31, 2023 are presented below:
 Stock OptionsRestricted StockPerformance Vested
Restricted Stock Units
 OptionsWeighted
Average
Exercise
Price
Weighted
Average
Remaining
Contractual
Term
SharesWeighted
Average
Grant Date
Fair Value
SharesWeighted
Average
Grant Date
Fair Value
Outstanding at January 1, 20231,010,647 $94.97 399,099 $128.47 437,180 $140.05 
Granted88,733 123.62 35,361 123.71 104,128 128.88 
Performance-Based Leveraging (1)
      
Exercised/Vested(107,252)52.25 (68,432)93.31 (120,308)145.41 
Expired      
Forfeited(645)123.71 (4,201)106.66 (960)139.95 
Outstanding at March 31, 2023991,483 $102.13 6.3361,827 $134.91 420,040 $135.78 
Options exercisable at March 31, 2023596,997 $90.05 4.8
(1) There has been no change to PVRSUs outstanding in the three months ended March 31, 2023 based on the Company's performance relative to the targeted performance conditions contained in PVRSUs.
Schedule of Weighted Average Assumptions of Black-Scholes Option-Pricing Model The fair value of the options granted during the three months ended March 31, 2023 was estimated on the grant date using the Black-Scholes option-pricing model with the following weighted average assumptions:
Risk-free interest rate4.10 %
Expected volatility30.90 %
Expected life of stock option6.0 years
Dividend yield0.9 %
Requisite service period4 years
Contractual life10 years
Weighted average fair value of options granted (per option)$42.59